Role of autoreactive CD8+ T cells in organ-specific autoimmune diseases: Insight from transgenic mouse models

Immunological Reviews

Volumn 169, Issue , 1999, Pages 81-92

  Vizler, Csaba ^a   Bercovici, Nadège ^a   Cornet, Anne ^a   Cambouris, Christophe ^a   Liblau, Roland S ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; HUMAN; IMMUNOTHERAPY; KNOCKOUT MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNE DISEASES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; PHENOTYPE;

EID: 0032795784     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01308.x     Document Type: Review

References (91)

1. 1. Tisch R. McDevitt HO. Insulin-dependent diabetes mellitus. Cell 1996;85:291-297.
2. 2. Delovitch TL, Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1997;7:727-738.
3. 3. Benoist C, Mathis D. Cell death mediators in autoimmune diabetes-no shortage of suspects. Cell 1997;89:1-3.
4. + T cells. J Exp Med 1987;166:823-832.
5. + T cell subsets are required for the transfer of diabetes in non-obese diabetic mice. J lmmunol 1988;140:52-58.
6. + T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur J lmmunol 1992;22:2387-2393.
7. + T cell dependent. J Immunol 1991;146:85-88.
8. d monoclonal antibody. Diabetes 1991;40:1203-1209.
9. + T cells in the initiation of insulin-dependent diabetes mellitus. Eur J Immunol 1996;26:1762-1769.
10. 10. Green EA, Eynon EE, Flavell RA. Local expression of TNFα in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity 1998;9:733-743.
11. + T and B lymphocytes. J lmmunol 1998;161:4420-4427.
12. 12. Katz J. Benoist C. Mathis D. Major histocompatibility complex class I molecules are required for the development of insulitis in nonobese diabetic mice. Eur J lmmunol 1993;23:3358-3360.
13. null nonobese diabetic mice. J Immunol 1996;157:3688-3693.
14. 14. Serreze DV, et al. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J Immunol 1997;158:3978-3986.
15. 15. Di Lorenzo T, et al. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor α chain gene rearrangement. Proc Natl Acad Sci USA 1998;95:12538-12543.
16. 16 Peterson JD, Haskins K. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells. Diabetes 1996;45:328-336.
17. 17. Kurrer MO, Pakala SV, Hanson HL, Katz JD. β cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci USA 1997;94:213-218.
18. 18. Kau. J, Benoist C, Mathis D. T helper cell subsets in insulin dependent diabetes. Science 1995;268:1185-1188.
19. + cytotoxic T cells in the destruction of pancreatic β-cells in nonobese diabetic mice. J Immunol 1994;152:2042-2050.
20. 20. Wong FS. Visintin I, Flavell RA, Janeway CA. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med 1996;183:67-76.
21. 21. Yoneda R, et al, CD8 cytotoxic T-cell clone rapidly transfers autoimmune diabetes in very young NOD and MHC class I-compatible scid mice. Diabetologia 1997;40:1044-1052.
22. 22. Chervonsky AV, et al. The role of Fas in autoimmune diabetes. Cell 1997;89:17-24.
23. 23. Allison J, Strasser A. Mechanisms of β cell death in diabetes: a minor role for CD95. Proc Natl Acad Sci USA 1998;95:13818-13822.
24. 24. Kägi D, et al. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J Exp Med 1997;186:989-997.
25. + lymphocytes in autoimmune disease. Studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice. J Immunol 1989;143:3994-3999.
26. 26. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgeneic model: role of anti-self (virus) immune response. Cell 1991;65:319-331.
27. 27. Ohashi PS, et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991;65:305-317.
28. 18. laufer TM, et al. Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice. J Exp Med 1993;178:589-596.
29. 29. Von Herrath MG, Dockter J, Oldstone M. How virus induces a rapid or slow onset insulin dependent diabetes mellitus in a transgeneic model. Immunity 1994;1:231-142.
30. 30. Von Herrath MG, et al. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. J Iminunol 1998;161:5087-5096.
31. 31. Von Herrath MG, Guerder S, Lewicki H, Flawell RA, Oldstone MB, Coexpression of B7-1 and viral ("self") transgenes in pancreatic β cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 1995;3:727-38.
32. 32. Kagi D, Odermatt B. Ohashi PS, Zinkernagel RM, Hentgartner H. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytoxicity. J Exp Med 1996;183:2143-2112.
33. + T cell-mediated spontaneous diabetes in neonatal mice. J Immunol 1996;157:978-983.
34. + T cells. Eur J Immunol 1992;22:1013-1022.
35. 35. Degermann S, et al. On the various manifestations of spontaneous autoimmune diabetes in rodent models. Eur J Immunol 1994;24:3155-3160.
36. 36. Scott B, et al, A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity Immunity 1994;1:73-82.
37. 37. Sarukhan A. Garda C, Lanoue A, von Boehmer H. Allelic inclusion of T cell receptor α genes poses an autoimmune hazard due to low-level expression of autospecific receptors. Immunity 1998;8:563-570.
38. + T cells expressing endogenous T cell receptor chains protect rnyelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med 1998;188:1883-1894.
39. 39. Hammerling GJ, Schönrich G, Ferber I, Arnold B. Peripheral tolerance as a multi-step mechanism. Immunol Rev 1993;133;93-104.
40. 40. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994;12:991-1045.
41. 41. Blanas E, Carbone FR, Allison J, Miller JFAP, Heath WR. Induction of autoimmune diabetes by oral administration of autoantigen. Science 1996;274:1707-1709.
42. 42. Kurts C, Miller JFAP, Subramaniam RM, Carbone FR, Heath WR. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med 1998;188:409-414.
43. 43. Verdaguer J, et al. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med 1997;186:1663-1676.
44. + T cells specific for a pancreatic β cell neo-antigen. Immunity 1995;2:573-585.
45. 45. Boitard C, Yasunami R, Dardenne M, Bach JF, T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 1989;169:1669-1680.
46. + T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice. J Exp Med 1998;188:1875-1882.
47. 47. Kurts C, et al. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996;184:923-930.
48. 48. Albert ML, Sauter B, Bhardwaj Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;392:86-89
49. 49. Guerder S, Matzinger P. A fail-safe mechanism for maintaining self tolerance. J Exp Med 1992;176:553-564.
50. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med 1997;186:2057-2061.
51. 51. Rachmann MF, et al. T cell responses are governed by avidity and costimulatory thresholds. Eur J Immunol 1996;26:2017.
52. + T tell activation. Int Immunol 1998;10:619-630.
53. 53. Delon J. et al. CD8 expression allows T cell signaling by monomeric peptide MHC complexes. Immunity 1998;9:467-473.
54. 54. Boniface JJ, et al. Initiation of signal transduction through the T cell receptor requires the peptide multivalent engagement of MHC ligands. Immunity 1998;9:459-466.
55. 55. Harlan DM, et al. Mice expressing both B7. I and viral glycoprotein on pancreatic β cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T lymphocyte unresponsiveness. Proc Natl Acad Sci USA 1994;91:3137-3141
56. 56. Garcia KC, et al. Structural basis of plasticity in T cell receptor recognition of a self neptide-MHC antigen. Science 1998;279:1116-1172.
57. 57. Hemmer B, et al. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med 1997;185:1651-1659.
58. -/- mice. Science 1992;256:1210-1213.
59. + T cells in murine experimental allergic encephalomyelitis. Science 1992;256:1213-1215.
60. + T cells. Proc Natl Acad Sci USA 1998;95:4533-4537.
61. 61. Kumar V, et al. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells, J Immunol 1997;159:5150-5156.
62. + T lymphocytes. J Immunol 1989;142:748-751.
63. 63. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL, Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc Natl Acad Sci USA 1992;89:421-425.
64. + cells mediate active suppression. J lmmunol 1995;155:910-916.
65. 65. Lindsey JW, Steinman L. Competitive PCR quantification of CD4, CD8, ICAM-1, VCAM-1, and MHC class II mRNA in the central nervous system during the development and resolution of experimental allergic encephalomyelitis. J Neuroimmunol 1993;48:227-234.
66. 66. Zhang BN, Yamamura T, Kondo T, Fujiwara M, Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells J Exp Med 1997;186:1677-1687.
67. 67. Evans CF, Horwitz MS, Hobbs MV, Oldstone MBA. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease, J Exp Med 1996;184:2371-2384.
68. + T cells in multiple sclerosis. Autoimmunity 1996;23:127-138.
69. 69. Reinhertz EL, et al. Loss of suppression T cells in active multiple sclerosis. N Engl J Med 1980;303:125-129.
70. 70. Vrethem M, et al, CD4 and CD8 lymphocyte subsets in cerebrospinal fluid and peripheral blood from patients with multiple sclerosis, meningitis and normal controls. Ada Neurol Scand 1998;97:215-220.
71. + T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J Virol 1998;72:7310-7329.
72. 72. Hauser SL, et al. Immunohistochemical staining of human brain with monoclonal antibodies that identify lymphocytes, monocytes and Ia antigen. Ann Neurol 1986;19:578-587.
73. 73. Traugou U. Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development. J Neuroimmunol 1987;16:283-302.
74. 74. Lucchinetti CF, Bruck W, Rodriguez M, Lassman H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity of pathogenesis. Brain Pathol 1996;6:259-274.
75. 75. Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O. Multiple sclerosis: a modifying influence of HLA class I in an HLA class II associated autoimmune disease J Neuroimmunol 1998;90:103.
76. + T-cell responses to human myelin protein-derived peptides. Proc Natl Acad Sci USA 1994;91:10859-10863.
77. 77. Dressel A, et al. Autoantigen recognition by human CD8 T cell clones. Enhanced agonist response induced by altered peptide ligands, J Immunol 1997;159:4943-951.
78. + cytotoxic T lymphocytes restricted by HLA-A3: evidence for cross-reactivity with an environmental microorganism. J Neuroimmunol 1997;73:7-14.
79. 79. Schwartz R. Direct visualization of antigen-specific cytotoxic T cells. A new insight into immune defenses. N Engl J Med 1998;339:1076-1078.
80. 80. Jurewicz A, Biddison WE, Antel JP. MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J Immunol 1998;160:3056-3059.
81. + T cells. J Immunol 1997;158:3046-3053.
82. 82. Albert ML, et al. Tumor-specific killer cells in paraneoplastic cerebellar degeneration, Nat Med 1998;4:1321-1324.
83. 83. Neumann H, Cavalie A. Jenne DE, Wekerle H. Induction of MHC class I genes in neurons. Science 1995;269:549-552.
84. 84. Corriveau RA, Huh GS, Shatz CJ. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity. Neuron 1998;21:505-520.
85. 85. Bottazzo GF, et al. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 1985;313:353-360.
86. 86. Itoh N, et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 1993;92:2313-2322.
87. 87. Somoza N, et al. Pancreas in recent onset insulin-dependent diabetes mellitus. J Immunol 1994;153:1360-1377.
88. 88. Sibley RK, Sutherland DER, Goetz F, Michael AF, Recurrent diabetes mellitus in the pancreas iso-and allograft. Lab Invest 1985;53:132-144.
89. + T-cell subsets in patients with newly diagnosed IDDM. Diabetes 1995;44:1414-1419.
90. + T-cells characterizes prediabetic twins. Diabetes Care 1996;19:1177-1184.
91. 91. Liblau R, Tisch R, Bercovici N, McDevitt HO. Systemic antigen in the treatment of T cell-mediated autoimmune diseases. Immunol Today 1997;18:599-604.